Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 8.6% - What's Next?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) shares fell 8.6% during mid-day trading on Monday . The stock traded as low as $14.26 and last traded at $14.33. 296,996 shares traded hands during mid-day trading, an increase of 19% from the average session volume of 249,120 shares. The stock had previously closed at $15.67.

Analyst Ratings Changes

KMTS has been the subject of several recent analyst reports. Bank of America began coverage on shares of Kestra Medical Technologies in a research note on Monday, March 31st. They issued a "buy" rating and a $30.00 target price for the company. Stifel Nicolaus assumed coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set a "buy" rating and a $28.00 target price for the company. Wells Fargo & Company started coverage on Kestra Medical Technologies in a report on Monday, March 31st. They issued an "overweight" rating and a $28.00 price target for the company. The Goldman Sachs Group dropped their price objective on Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating on the stock in a report on Wednesday, April 16th. Finally, Wolfe Research initiated coverage on Kestra Medical Technologies in a report on Monday, March 31st. They issued an "outperform" rating and a $29.00 target price for the company. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $27.50.

Kestra Medical Technologies Stock Down 1.4%

The firm has a fifty day moving average of $19.71.

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last issued its quarterly earnings data on Monday, April 14th. The company reported ($1.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by ($0.61). During the same period in the previous year, the business posted ($1.18) earnings per share.

Institutional Trading of Kestra Medical Technologies

A number of large investors have recently made changes to their positions in KMTS. Quarry LP purchased a new position in Kestra Medical Technologies in the 1st quarter valued at about $33,000. Virtu Financial LLC purchased a new position in shares of Kestra Medical Technologies during the first quarter valued at approximately $210,000. Armistice Capital LLC acquired a new stake in Kestra Medical Technologies during the first quarter worth approximately $312,000. Zimmer Partners LP acquired a new position in Kestra Medical Technologies in the 1st quarter valued at $374,000. Finally, Russell Investments Group Ltd. purchased a new position in shares of Kestra Medical Technologies during the 1st quarter worth $457,000.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.